Haleon plc (HLNCF)
OTCMKTS · Delayed Price · Currency is USD
5.10
+0.21 (4.29%)
Jan 6, 2026, 4:00 PM EST
Haleon Market Cap
Haleon has a market cap or net worth of $45.27 billion as of January 7, 2026. Its market cap has increased by 4.97% in one year.
Market Cap
45.27B
Enterprise Value
55.96B
Revenue
15.10B
Ranking
n/a
PE Ratio
21.71
Stock Price
$5.10
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from 34.14B to 45.27B, an increase of 32.57%. That is a compound annual growth rate of 8.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 44.82B | -0.24% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |